Company Overview of Alevium Pharmaceuticals Inc.
Alevium Pharmaceuticals Inc. operates as a biopharmaceutical company. The company specializes in treating poor responders of proton pump inhibitors (PPIs) with acid regulation. Its API 023 is an oral and intravenous PPI for the treatment of gastrointestinal acid-related disorders. The company’s API-023 is a prodrug of omeprazole designed to address significant unmet medical needs in acid-related disorders. Alevium Pharmaceuticals Inc. was incorporated in 2008 and is based in Encinitas, California.
1550 Neptune Avenue
Encinitas, CA 92024
Founded in 2008
Key Executives for Alevium Pharmaceuticals Inc.
Similar Private Companies By Industry
|Crofelemer Access Program (CAP) Global LLC||United States|
|Nuovo Biologics, L.L.C.||United States|
|SinoFresh Healthcare Inc.||United States|
|Cardioxyl Pharmaceuticals, Inc.||United States|
|Liddell Laboratories, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Alevium Pharmaceuticals Inc., please visit www.alevium.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.